Article Details

Exelixis Expands its Biotherapeutics Portfolio with Acquisition of GamaMabs Pharma's First-in ...

Retrieved on: 2021-05-04 12:00:00

Tags for this article:

Click the tags to see associated articles and topics

Exelixis Expands its Biotherapeutics Portfolio with Acquisition of GamaMabs Pharma's First-in .... View article details on hiswai:

Excerpt

Early clinical data of naked monoclonal antibodies support safety of ... Antibody-drug conjugates (ADCs) targeting AMHR2 could provide clinical ...

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo